The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy and safety of docetaxel-based chemotherapy in Japanese men over 80 years old with castration-resistant prostate cancer.
Takeo Kosaka
No relevant relationships to disclose
Yota Yasumizu
No relevant relationships to disclose
Ryuichi Mizuno
No relevant relationships to disclose
Akira Miyajima
No relevant relationships to disclose
Eiji Kikuchi
No relevant relationships to disclose
Morita Shinya
No relevant relationships to disclose
Hidaka Kono
No relevant relationships to disclose
Ken Nakagawa
No relevant relationships to disclose
Mototsugu Oya
No relevant relationships to disclose